Tibsovo(ivosidenib)
TIBSOVO 250 MG Oral Tablet

Dosage & Administration

500 mg orally once daily with or without food until disease progression or unacceptable toxicity . Avoid a high-fat meal.

Most viewed Tibsovo resources

Enroll in Patient Savings Program

Get Your Patient on Tibsovo

Find restrictionsSee step therapiesCompare coverage options
Insurance Carrier

Tibsovo Prior Authorization Resources

Most recent state uniform prior authorization forms

Verified: Sep 24, 2024Arizona - Uniform Prior Authorization Form
Verified: Sep 24, 2024Colorado - Uniform Prior Authorization Form
Verified: Sep 24, 2024Hawaii - Uniform Prior Authorization Form
Verified: Sep 24, 2024Illinois - Uniform Prior Authorization Form
Verified: Sep 24, 2024Indiana - Uniform Prior Authorization Form
Verified: Sep 24, 2024Louisiana - Uniform Prior Authorization Form
Verified: Sep 24, 2024Minnesota - Uniform Prior Authorization Form
Verified: Sep 24, 2024New Hampshire - Uniform Prior Authorization Form
Verified: Sep 24, 2024New Mexico - Uniform Prior Authorization Form
Verified: Sep 24, 2024Oregon - Uniform Prior Authorization Form
Verified: Sep 24, 2024Texas - Uniform Prior Authorization Form
Verified: Sep 05, 2024Washington - Uniform Prior Authorization Form
Verified: Sep 05, 2024Wisconsin - Uniform Prior Authorization Form

Benefits investigation

Servier One Enrollment Form

Tibsovo Preferred Pharmacy

Pharmacy List

Tibsovo Financial Assistance Options

Copay savings program

Enroll in Patient Savings Program
Learn More

Bridge program

Servier One Enrollment Form
Bridge Program - Max 2 Month Supply
Learn More

Foundation programs

Servier One Enrollment Form
Patient Assistance Program
Learn More

Tibsovo PubMed™ News

Tibsovo Patient Education

To share resource; ask patient to:
1.Pull out phone
2.Open camera
3.Scan QR code with camera
4.Tap link

Patient toolkit

Other Patient Resources - Servier ONE for Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Acute Myeloid Leukemia (AML) Factsheet
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Cholangiocarcinoma (CCA) Factsheet
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Tibsovo: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Tibsovo: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Acute Myeloid Leukemia (AML)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
About Tibsovo: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Side Effects: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
View How to Take Tibsovo: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Resources: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link
Patient Brochure: Cholangiocarcinoma (CCA)
ASK PATIENT TO:
Open Camera on Phone
Scan QR Code & Tap Link

Tibsovo FAQs

How is the dosage of Tibsovo?
What does Tibsovo treat?
What is Tibsovo made of?
How Is Tibsovo Administered?
What Are The Tibsovo Mechanism Of Action?
FAQ Data Source